Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease

被引：1
|
作者：
Kesten, Steven [1 ]
Leimer, Inge [1 ]
Jara, Michele [2 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[2] Epidemiol Consulting, Danbury, CT USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2009年 / 301卷 / 12期
关键词：
TIOTROPIUM; TRIAL; COPD;
D O I：
10.1001/jama.2008.947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1224 / 1224
页数：1
相关论文
共 50 条
  • [21] INHALED STEROIDS AND RISK OF PNEUMONIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Angelia, Ferina
    Purwantyastuti, Purwantyastuti
    Soetikno, Vivian
    Amin, Zulkifli
    RESPIROLOGY, 2018, 23 : 241 - 242
  • [22] Do Inhaled Anticholinergics Increase or Decrease the Risk of Major Cardiovascular Events?A Synthesis of the Available Evidence
    Shelley R. Salpeter
    Drugs, 2009, 69 : 2025 - 2033
  • [23] Do Inhaled Anticholinergics Increase or Decrease the Risk of Major Cardiovascular Events? A Synthesis of the Available Evidence
    Salpeter, Shelley R.
    DRUGS, 2009, 69 (15) : 2025 - 2033
  • [24] The role of anticholinergics in chronic obstructive pulmonary disease
    Barnes, PJ
    AMERICAN JOURNAL OF MEDICINE, 2004, 117 : 24S - 32S
  • [25] Anticholinergics in the treatment of chronic obstructive pulmonary disease
    Beeh, KM
    Welte, T
    Buhl, R
    RESPIRATION, 2002, 69 (04) : 372 - 379
  • [26] Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study
    Valeria Raparelli
    Daniele Pastori
    Serena Francesca Pignataro
    Anna Rita Vestri
    Pasquale Pignatelli
    Roberto Cangemi
    Marco Proietti
    Giovanni Davì
    William Robert Hiatt
    Gregory Yoke Hong Lip
    Gino Roberto Corazza
    Francesco Perticone
    Francesco Violi
    Stefania Basili
    Internal and Emergency Medicine, 2018, 13 : 651 - 660
  • [27] Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study
    Raparelli, Valeria
    Pastori, Daniele
    Pignataro, Serena Francesca
    Vestri, Anna Rita
    Pignatelli, Pasquale
    Cangemi, Roberto
    Proietti, Marco
    Davi, Giovanni
    Hiatt, William Robert
    Lip, Gregory Yoke Hong
    Corazza, Gino Roberto
    Perticone, Francesco
    Violi, Francesco
    Basili, Stefania
    INTERNAL AND EMERGENCY MEDICINE, 2018, 13 (05) : 651 - 660
  • [28] Anticholinergics in the management of chronic obstructive pulmonary disease
    Alfageme Michavila, I.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2007, 43 (06): : 297 - 299
  • [29] Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular events
    Le Gall, Lisa
    Harambat, Jerome
    Combe, Christian
    Philipps, Viviane
    Proust-Lima, Cecile
    Dussartre, Maris
    Drueeke, Tilman
    Choukroun, Gabriel
    Fouque, Denis
    Frimat, Luc
    Jacquelinet, Christian
    Laville, Maurice
    Liabeuf, Sophie
    Pecoits-Filho, Roberto
    Massy, Ziad A.
    Stengel, Benedicte
    de Pinho, Natalia Alencar
    Leffondre, Karen
    Prezelin-Reydit, Mathilde
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (04) : 669 - 682
  • [30] Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    Crisan, Liliana
    Wong, Nathan
    Sin, Don D.
    Lee, Hwa Mu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2019, 6
12345